Two Sigma Securities’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,964
Closed -$286K 1813
2026
Q1
$286K Buy
+7,964
New +$206K 0.03% 805
2021
Q1
Sell
-11,326
Closed -$35K 969
2020
Q4
$35K Buy
+11,326
New +$39.5K ﹤0.01% 1575
2018
Q4
Sell
-12,727
Closed -$81K 2230
2018
Q3
$81K Buy
+12,727
New +$90.3K ﹤0.01% 2330
2018
Q2
Sell
-14,044
Closed -$99K 2679
2018
Q1
$99K Buy
+14,044
New +$104K ﹤0.01% 2439
2017
Q4
Sell
-10,877
Closed -$91K 1743
2017
Q3
$91K Buy
+10,877
New +$67.8K 0.01% 682

Other funds holding CLMT

Two Sigma Securities's CLMT Position: Q2 2026 in Review

Two Sigma Securities sold out of Calumet Specialty Products (CLMT) in Q2 2026, closing a stake of 7,964 shares — an estimated $286K sold.

Two Sigma Securities first reported a position in CLMT in Q3 2017 and held it in 5 quarters. The position peaked at $286K in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Two Sigma Securities reported no remaining Calumet Specialty Products position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 7,964 Calumet Specialty Products shares in Q2 2026, an estimated $286K.
  • Two Sigma Securities first reported a position in Calumet Specialty Products in Q3 2017 and held it in 5 quarters.
  • Two Sigma Securities's Calumet Specialty Products position peaked at $286K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.